Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
Rhea-AI Summary
Ceribell (Nasdaq: CBLL) announced that CFO Scott Blumberg will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference in Boston. The session is scheduled for Wednesday, August 12, 2026, at 6:00 a.m. PDT / 9:00 a.m. EDT, with a live and archived webcast available in the Investor Relations section of the Ceribell website.
Positive
- None.
Negative
- None.
News Market Reaction – CBLL
In the Jul 29 session, CBLL declined 0.56%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 20 | Earnings date notice | Neutral | -2.9% | Second-quarter results scheduled for release after market close on August 10 |
| Jun 08 | Clinical publication | Positive | -0.6% | Study linked AI-detected seizure burden with severe disability or death |
| May 20 | Growth conference participation | Neutral | +3.5% | CEO scheduled to present at William Blair growth stock conference |
| May 11 | Quarterly earnings report | Positive | -16.5% | First-quarter revenue increased 29% year over year with raised guidance |
| Apr 29 | Healthcare conference participation | Neutral | +4.7% | CEO and CFO scheduled for a Bank of America fireside chat |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent conference announcements were followed by positive reactions, while the prior earnings and publication events were followed by negative reactions despite positive or informational content.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SUNNYVALE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Scott Blumberg, CFO, will participate in a fireside chat at the upcoming Canaccord Genuity 46th Annual Growth Conference in Boston. The fireside chat will take place on Wednesday, August 12, 2026, at 6:00 a.m. Pacific Daylight Time / 9:00 a.m. Eastern Daylight Time.
Event: Canaccord Genuity 46th Annual Growth Conference
Date: Wednesday, August 12, 2026
Time: 6:00 a.m. PDT / 9:00 a.m. EDT
A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.
About CeriBell, Inc.
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute-care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared for use in detecting seizure and delirium in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visit www.ceribell.com or follow the company on LinkedIn.
Investor Contact
Brian Johnston
Gilmartin Group
Investors@ceribell.com
Media Contact
Brian Price
Press@ceribell.com
